Cargando…
Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
Autores principales: | Kuzumaki, Naoko, Suzuki, Atsuo, Narita, Michiko, Hosoya, Takahiro, Nagasawa, Atsumi, Imai, Satoshi, Yamamizu, Kohei, Morita, Hiroshi, Suzuki, Tsutomu, Okada, Yohei, Okano, Hirotaka James, Yamashita, Jun K., Okano, Hideyuki, Narita, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729805/ https://www.ncbi.nlm.nih.gov/pubmed/29220846 http://dx.doi.org/10.1371/annotation/49257f53-8cb1-431b-be64-7b410598b845 |
Ejemplares similares
-
Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer
por: Kuzumaki, Naoko, et al.
Publicado: (2012) -
Effect of κ-opioid receptor agonist on the growth of non-small cell lung cancer (NSCLC) cells
por: Kuzumaki, N, et al.
Publicado: (2012) -
к Opioids inhibit tumor angiogenesis by suppressing VEGF signaling
por: Yamamizu, Kohei, et al.
Publicado: (2013) -
Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c
por: Narita, Michiko, et al.
Publicado: (2017) -
Reduced expression of somatostatin in GABAergic interneurons derived from induced pluripotent stem cells of patients with parkin mutations
por: Iwasawa, Chizuru, et al.
Publicado: (2019)